News Arbutus Presents New Data on AB-729, AB-836 and AB-101 at the EASL International Liver Congress™ 2022 and Provides AB-836 Clinical Update Continue Reading Previous Immunocore announces the presentation of initial data from the Phase 1 ImmTAV® trial for chronic Hepatitis B at the EASL International Liver Congress™Next Vir Biotechnology Announces New Clinical Data From its Broad Hepatitis B Program Related Stories News TransNusa Launches Maiden Bali-Phuket Flight for the Ultimate Island-Hopping Experience News The 43rd Hong Kong Watch & Clock Design Competition results announced News Universitas Brawijaya Forest operates thermal drone to strengthen fire mitigation News YDC 2026 unveils its winners in spectacular fashion News TMX Group Consolidated Trading Statistics – August 2026 News Pioneer AI Foundry Board Composition Changes
